glp-1 thyroid Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges Implications of GLP-1 Receptor Agonist
Description
The meal replacement products market has become a fast-growing segment within the overarching health and wellness industry, meeting consumers growing needs for convenient, healthy, and functional diets, the report said
Enhanced Blood Sugar Control: By targeting both GLP-1 and GIP receptors, Tirzepatide offers enhanced blood sugar control, reducing the likelihood of insulin resistance
Rapid weight loss from appetite suppression can create calorie and nutrient shortfalls, prompting the body to redirect energy away from non-essential functions like hair growth
None of the treatments led to conditioned taste aversion (Supplementary Fig
PMCID: PMC5501083
